Atlas Private Wealth Advisors Bristol Myers Squibb CO Transaction History

Atlas Private Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $77,341 - $86,479	-1,336 Reduced 21.87%	4,774 $277,000
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $389,268 - $432,221	6,110 New	6,110 $390,000
Q4 2021 Apr 21, 2022	SELL	$53.63 - $62.52 $70,148 - $81,776	-1,308 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $2,958 - $3,465	-50 Reduced 3.68%	1,308 $77,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $37,455 - $40,789	-605 Reduced 30.82%	1,358 $91,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $1,732 - $1,962	-30 Reduced 1.51%	1,963 $122,000
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 4.78%	1,993 $120,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $114,738 - $134,140	2,093 New	2,093 $123,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.